Insights

Nordic footprint Navamedic operates across all Nordic countries, the Baltics, and Benelux with broader European exposure, signaling multiple regional entry points for new product partnerships, distribution deals, and co-marketing opportunities.

Regulatory edge A strong team in regulatory affairs, quality assurance, and reimbursement implies readiness to accelerate market access for new medicines, medical devices, and nutraceuticals, making Navamedic a favorable partner for launches requiring compliance expertise.

Recent leadership Significant leadership changes with a new CEO appointed mid-2026 present an opening to align on strategic partnerships, joint ventures, and accelerated go-to-market plans to capitalize on fresh strategic direction.

Product portfolio Portfolio spans prescription and OTC pharmaceuticals, medical nutrition, devices, supplements, and cosmetics, offering cross-category collaboration potential with healthcare providers and pharmacies to bundle solutions.

Digital & partnerships Past collaborations in digital health (Parkinson’s care app) and active online presence indicate opportunities to co-develop or distribute digital health solutions, telemedicine integrations, and patient-support programs aligned with Navamedic’s products.

Similar companies to Navamedic ASA

Navamedic ASA Tech Stack

Navamedic ASA uses 8 technology products and services including iCIMS, Amazon Web Services, WordPress, and more. Explore Navamedic ASA's tech stack below.

Media & News

Navamedic ASA's Email Address Formats

Navamedic ASA uses at least 4 email formats:
Navamedic ASA Email FormatsExamplePercentage
First.Last@navamedic.comJohn.Doe@navamedic.com
79%
Last.First@navamedic.comDoe.John@navamedic.com
12%
First.Middle.Last@navamedic.comJohn.Michael.Doe@navamedic.com
6%
FL@navamedic.comJD@navamedic.com
3%

Frequently Asked Questions

What is Navamedic ASA's official website and social media links?

Minus sign iconPlus sign icon
Navamedic ASA's official website is navamedic.com and has social profiles on LinkedIn.

How much revenue does Navamedic ASA generate?

Minus sign iconPlus sign icon
As of August 2026, Navamedic ASA's annual revenue is estimated to be $1M - $10M.

What is Navamedic ASA's SIC code and NAICS code?

Minus sign iconPlus sign icon
Navamedic ASA's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Navamedic ASA have currently?

Minus sign iconPlus sign icon
As of August 2026, Navamedic ASA has approximately 52 employees across 2 continents, including Europe and North America. Key team members include Ceo: K. G. A., Chief Financial Officer: N. O. K. and Chief Scientific Officer: A. T. B. Explore Navamedic ASA's employee directory with LeadIQ.

What industry does Navamedic ASA belong to?

Minus sign iconPlus sign icon
Navamedic ASA operates in the Pharmaceutical Manufacturing industry.

What technology does Navamedic ASA use?

Minus sign iconPlus sign icon
Navamedic ASA's tech stack includes iCIMS, Amazon Web Services, WordPress, Shopify, Mailgun, Microsoft 365, New Relic and Piwik PRO Core.

What is Navamedic ASA's email format?

Minus sign iconPlus sign icon
Navamedic ASA's email format typically follows the pattern of First.Last@navamedic.com. Find more Navamedic ASA email formats with LeadIQ.

When was Navamedic ASA founded?

Minus sign iconPlus sign icon
Navamedic ASA was founded in 2002.
Navamedic ASA logo

Navamedic ASA

Pharmaceutical ManufacturingOslo, Norway51-200 Employees

Navamedic ASA operates as a Nordic pharmaceutical company that supplies high-quality products to hospitals and pharmacies, addressing the medical needs of patients and consumers. Its portfolio spans prescription and over-the-counter medicines as well as medical nutrition products, medical devices, food supplements, and cosmetics. Headquartered in Oslo, Norway, the business operates across Nordic countries, the Baltics, and Benelux, and is listed on the Oslo Stock Exchange. 
As a relatively small to mid-sized firm, Navamedic functions as a full-service provider, coordinating regulatory affairs, quality assurance, reimbursement, and commercial activities to secure market access for its products in these regions and other European markets such as the UK and Greece. Its customers include hospitals and pharmacies, through which medicines and health-related products reach patients and consumers. A notable development in 2026 was the launch of Virono, a single-dose OTC tablet for cold sores.

Section iconCompany Overview

SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $1M - $10M

    Navamedic ASA's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.